Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Highlights • Thrombocytopaenia is common in patients with chronic liver disease. • Lusutrombopag increased platelet count ≥1.5-fold in most patients with chronic liver disease-induced thrombocytopaenia. • Lusutrombopag doubled platelet count in half of patients treated. • Lusutrombopag-induced platelet count increases (without platelet transfusion) lasted for 3 weeks.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
